ASX - By Stock
|
SPL |
Re:
Ann: Change in substantial holding
|
|
Esmer
|
13 |
2.5K |
0 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
13
|
2.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Multibagger (10x)
|
|
Esmer
|
25 |
6.1K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
25
|
6.1K
|
2
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.7M |
2 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
16K
|
2.7M
|
2
|
|
ASX - By Stock
|
LSF Managed Funds |
Re:
Charts
|
|
Esmer
|
27 |
10K |
0 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
27
|
10K
|
0
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.7M |
7 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
16K
|
2.7M
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Slow death
|
|
Esmer
|
39 |
9.1K |
8 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
39
|
9.1K
|
8
|
|
ASX - By Stock
|
XJO |
Re:
Indices 10/06
|
|
Esmer
|
21 |
3.4K |
1 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
21
|
3.4K
|
1
|
|
ASX - By Stock
|
LSF |
Re:
Ann: On-market share buy back
|
|
Esmer
|
21 |
6.1K |
3 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
21
|
6.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
Esmer
|
17 |
5.3K |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
5.3K
|
6
|
|
ASX - By Stock
|
LSF |
Re:
Ann: On-market share buy back
|
|
Esmer
|
21 |
6.1K |
0 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
21
|
6.1K
|
0
|
|
ASX - By Stock
|
HM1 |
Re:
Ann: April Investment Update
|
|
Esmer
|
10 |
3.1K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
10
|
3.1K
|
1
|
|
ASX - By Stock
|
XJO |
Re:
06/05 Indices
|
|
Esmer
|
49 |
7.8K |
5 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
49
|
7.8K
|
5
|
|
ASX - By Stock
|
XJO |
Re:
Indices 29/4
|
|
Esmer
|
43 |
7.4K |
15 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
43
|
7.4K
|
15
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.7M |
6 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
16K
|
2.7M
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
Esmer
|
22 |
4.6K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
Esmer
|
22 |
4.6K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.6K
|
0
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.7M |
8 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
16K
|
2.7M
|
8
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Net Tangible Asset Backing
|
|
Esmer
|
4 |
1.6K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4
|
1.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Esmer
|
150 |
31K |
7 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
150
|
31K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Esmer
|
150 |
31K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
150
|
31K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
Esmer
|
150 |
31K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
150
|
31K
|
2
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Joint MD - Medical Leave
|
|
Esmer
|
4 |
1.5K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Net Tangible Asset Backing
|
|
Esmer
|
5 |
1.8K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5
|
1.8K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
Indices 01/04
|
|
Esmer
|
101 |
17K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
101
|
17K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.7M |
8 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
16K
|
2.7M
|
8
|
|
ASX - By Stock
|
XJO |
Re:
Indices 4/3
|
|
Esmer
|
77 |
13K |
5 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
77
|
13K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
Esmer
|
72 |
14K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
72
|
14K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV US FDA Appeal Outcome
|
|
Esmer
|
60 |
13K |
3 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
60
|
13K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
Esmer
|
72 |
14K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
72
|
14K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
12/02 Indices
|
|
Esmer
|
146 |
21K |
8 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
146
|
21K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Capital raising this Quarter ?
|
|
Esmer
|
15 |
3.6K |
6 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
15
|
3.6K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Capital raising this Quarter ?
|
|
Esmer
|
15 |
3.6K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
15
|
3.6K
|
1
|
|
ASX - By Stock
|
XJO |
Re:
29/01 Indices
|
|
Esmer
|
145 |
20K |
5 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
145
|
20K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Viraleze shows antiviral efficacy in COVID-19 patients
|
|
Esmer
|
74 |
15K |
3 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
74
|
15K
|
3
|
|
ASX - By Stock
|
SPL |
SPL January 2024 technical analysis
|
|
Esmer
|
1 |
605 |
4 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
1
|
605
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Letter from Cheryl..
|
|
Esmer
|
72 |
17K |
9 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
72
|
17K
|
9
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Results of General Meeting
|
|
Esmer
|
40 |
9.4K |
5 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
40
|
9.4K
|
5
|
|
ASX - By Stock
|
SPL |
Seasons Greetings
|
|
Esmer
|
1 |
511 |
6 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
1
|
511
|
6
|
|
ASX - By Stock
|
XJO |
Re:
11/12 Indices
|
|
Esmer
|
181 |
24K |
5 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
181
|
24K
|
5
|
|
ASX - By Stock
|
XJO |
Re:
04/12 Indices
|
|
Esmer
|
164 |
24K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
164
|
24K
|
1
|
|
ASX - By Stock
|
XJO |
Re:
04/12 Indices
|
|
Esmer
|
164 |
24K |
3 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
164
|
24K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
04/12 Indices
|
|
Esmer
|
164 |
24K |
3 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
164
|
24K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Another ADC Buyout - Just not SPL
|
|
Esmer
|
23 |
5.8K |
3 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
23
|
5.8K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
Generall Meeting 2024 - my opinion
|
|
Esmer
|
149 |
52K |
7 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
149
|
52K
|
7
|
|
ASX - By Stock
|
XJO |
Re:
20/11 Indices
|
|
Esmer
|
83 |
13K |
3 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
83
|
13K
|
3
|
|
ASX - By Stock
|
XJO |
Re:
20/11 Indices
|
|
Esmer
|
83 |
13K |
2 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
83
|
13K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
The window is now open - D day is here
|
|
Esmer
|
43 |
11K |
4 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
43
|
11K
|
4
|
|
ASX - By Stock
|
XJO |
Re:
20/11 Indices
|
|
Esmer
|
83 |
13K |
1 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
83
|
13K
|
1
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
Esmer
|
16K |
2.7M |
4 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
16K
|
2.7M
|
4
|
|
ASX - By Stock
|
SPL |
Re:
ADVERTISING
|
|
Esmer
|
16 |
3.5K |
2 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
16
|
3.5K
|
2
|
|